Clinical Pharmacology Details


Miconazole Nitrate


View Drug Forms

Indications & Dose:

Fungal infection of oropharyn-geal cavity & G. I. tract.


DOSE


Local applications 2-3 times daily

Contraindications:

Side Effects:

Cautions:

Precautions:

Renal disease, hepatic disease

Interaction:

Drugs
 



Drugs


Aminogl ycosides: Decreased antibiotic peak levels


Astemizole: QT prolongation and arrhythmia


Cisapride: Increased cisapride concentrations, toxicity and arrhythrnias


Coumarin drugs: Enhanced anticoagulant effect


Cyclosporine: Possible increased cyclosporine levels


Felodipine: Enhanced vasodilation, hypotension


HMG-CoA reductase inhihitors (e.g. lavastatin): Increased toxicity, rhabdomyolysis


Loratadine: Increased loratadine concentrations


Midazolam: Reduced midazolam metabolism


Quinidine: Increased quinidine concentrations


Tacrolimus: Possible increased tacrolimus levels


Tolbutamide: Inhibition of tolbutamide metabolism


Triazolam: Reduced triazolam metabolism


Warfarin: Enhanced anticoagulant effect 

Warnings:

Adverse Effects:

Lactations:

Pregnancy category C (Top category B); unknown if excreted into breast milk

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

CNS: Drowsiness, headache 
CV: Dysrhythmias (rapid IV), tachycardia
GI: Anorexia, cramps, diarrhea, nausea, vomiting (IV)
GU: Hyponatremia, itching, pelvic cramps (topical forms), vulvovaginal burning
HEME: Thrombocytapenia
METAB: Hyperlipidemia (due to vehicle in IV prep)
SKIN: Fever, flushing, hives, phlebitis (IV), pruritus, rash 

Patient And Carer Advice: